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ABSTRACT 
 
An  adsorptive  stripping  voltammetric  procedure  for  the  determina- tion  of  the  antidepressant  
venlafaxine  in  urine  using  a  mercury  film microelectrode  was  developed.  The  method  is  based  on  
controlled adsorptive accumulation of the drug at the potential of -1.00 V (vs. Ag/AgCl)  in  the  
presence  of  1.25 x 10-2 mol L-1   borate  buffer  (pH 8.7).   Urine   samples   were   analyzed   directly   
after   performing   a ten-fold  dilution  with  the  supporting  electrolyte  but  without  other 
pretreatment.  The  limit  of  detection  obtained  for  a  30 s  collection time   was   0.693 x 10-6 mol 
L-1.   Recovery   experiments   gave   good results  at the  10-6 mol L-1  level  (bias  less  5%  were  
obtained). 
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INTRODUCTION 
 
Venlafaxine (1-[2-(Dimethylamino)-1-(methoxyphenyl)ethyl]cyclo- hexanol hydrochloride; V) is a novel 
nontricyclic  antidepressant available in the European market since 1997. V, like the tricyclic 
antidepressants, imparts antidepressant effects by inhibiting the neuronal uptake of norepinephrine, 
serotonin, and to a lesser extent dopamine.[1] It lacks monoamine oxidase inhibitory activity and, more 
importantly, lacks the adverse effect profile of tricyclic antidepres- sants.[1] Clinical manifestations of 
toxicity and untoward side effects include anxiety, nervousness, and insomnia.[2] Increasingly, the 
monitoring  of  drugs  in  biological  fluids,  such  as  plasma  and   urine, is being considered a  rational  
approach  for  the  correct  management of patient therapy and for minimizing  side  effects.  
Accordingly, methods involving, exclusively, extractions with organic solvents, followed by assay by gas 
chromatography[2]  and  high  performance liquid  chromatography[3]  have  been  reported  for  the   
determination of  this drug  in  biological  fluids.  The  polarographic   behavior   of  V has  been  studied  
previously  by  one  of  us  and  applied   successfully to the analysis of two pharmaceutical 
formulations.[4] Several authors have claimed and proved that the use of mercury film electrodes is 
analytically advantageous over the use of hanging mercury drop electrode.[5–6] Furthermore, mercury 
film electrodes, principally if microelectrodes are utilized, are, environmentally, much less aggressive 
since  lower  quantities  of  contaminated  effluent  are produced. 
The aim of the present study was to investigate the adsorptive behav- ior of V in a biological fluid, 
urine, using a mercury film microelectrode (MFM) and to develop a simple and accurate stripping 
voltammetric procedure for its routine therapeutic or toxic dose monitoring in urine. Adsorptive 
 voltammetry, which has been proven suitable for the quanti- fication of a large variety of biologically 
significant organic molecules,[7–8] when coupled with the inherent properties of microelectrodes[9–
10] has shown to be a reliable and promising  technique.[11–13] 
  
 
  
 
EXPERIMENTAL 
 
Reagents 
 
The   mercury   deposition   solution   was   a   deoxygenated   solution containing    1.00 mol L-1     
potassium    nitrate    plus    5.70 x 10-3 mol L-1 mercury  (II)  nitrate  and  0.500  %  (V/V)  nitric  acid  
(65%).[14] 
Stock standard solutions of V hydrochloride (Effexor, Wyeth-Ayerst Laboratories)    of    1.59 x 10-3 mol 
L-1      and    3.29 x 10-3 mol L-1     were prepared   by  dissolving  the  exact  weight  of  the  active  
component  in deionized  and  triply  distilled  water  each  week.  Solutions  were  stored  at 4oC  and  
protected  from  light. 
The  supporting  electrolyte  was  borate  buffer,  pH ¼ 8.7  (1.25 x 10-2 mol L-1      sodium    tetraborate    
decahydrate    and    1.20 x 10-2 mol L-1 hydrochloride   acid).   For   pH   studies,   the   Britton-Robinson   
buffer[15] was  prepared  with  4.00 x 10-2 mol L-1   acetic  acid,  4.00 x 10-2 mol L-1 phosphoric acid 
and 4.00 x 10-2 mol L-1  boric acid. Required pH values were adjusted by addition of 0.500 mol L-1  or 
5.00 mol L-1  hydrochloride acid  or  sodium  hydroxide.  All  reagents  used  were  of  analytical  reagent 
grade (Merck). Deionized and triply distilled water was used for preparing all solutions. 
 
 
Apparatus 
 
An  AUTOLAB  potentiostat/galvanostat  model  PSTAT  10  coupled with an ECD Module from 
EcoChemie controlled by a PC, through the Model GPES3 software, was used for all electrochemical 
measurements. The Voltammetric studies were performed with a working MFM using an Ag/AgCl/3.00 mol 
L-1   potassium  chloride  reference  electrode  (to  which all  the  potential  values  are  referred)  and  a  
cylindrical  carbon  counter electrode.   Electrical   connections   were   made   with   low   noise   coaxial cables  
and  the  electrochemical  system  was  placed  inside  a  thick-walled aluminum  Faraday  cage. 
 
 
Procedures 
 
In the beginning of each working  day,  a  gold  microelectrode (radius ¼ 12.5 mm; purchased from the 
Department of Chemistry of the University of Southampton) was polished with 0.015 mm alumina, and 
rinsed abundantly with deionized water until a perfect cyclic steady-state 
  
 
(sigmoidal)   voltammogram   was   obtained   in   a   solution   containing 0.100 mol L-1  of  iron  (III)/iron  
(II)  in  1.00 mol L-1  of  potassium  nitrate aqueous  solution.[16] 
Then, the working MFM was prepared by electrodeposition of a mercury film onto the gold microdisk 
by the application of a constant potential of 0.00 V during a deposition time of 60 s from the 
mercury deposition solution.[14] The MFM was removed, rinsed with deionized and triply distilled 
water and inserted in the solution to be   analyzed. 
Urine samples were obtained from healthy volunteers and were spiked with an adequate amount of 
the drug to give the desired final concentration. 
For the voltammetric studies, the test solutions constituted by urine samples ten-fold diluted with the 
supporting electrolyte (pH ¼ 8.7) were purged with nitrogen (99.99% from LINDE Portugal) for 15 
min, then the gas stream was directed over the solution surface. The preconcentra- tion was 
accomplished in quiescent solutions at the optimal potential   of -1.00 V  during  a deposition  time  of  
10 s. Following  the  cathodic poten- tial  scan,  a  conditioning  potential  of  -2.00 V  was  applied  to  the  
MFM during  30 s.  The  square-wave  parameters  used  (except  where  otherwise stated) were a 
frequency of 100 Hz, an amplitude of 20 mV and a staircase of  5 mV.  The  quantifications  were  
achieved  by  the  standard  additions  method. 
 
 
RESULTS  AND DISCUSSION 
 
In order to study the adsorptive behavior of V in urine, a series of optimization studies was carried 
out. Several parameters were investi- gated, namely, reaction irreversibility, deposition potential, 
reproducibil- ity, pH, deposition time, frequency, amplitude, staircase step, linearity range, and 
detection limit. Recovery experiments were performed to evaluate the accuracy of the developed 
electrochemical  method. 
 
 
Adsorption  and Irreversibility 
 
Figure   1   illustrates   two   successive   cyclic   voltammograms    for 
19.7 mmol L-1  of V recorded at a scan rate of 100 mV s-1  after accumula- tion at -1.00 V during 10 
s. A cathodic peak, due to the reduction of the adsorbed  drug,  is  observed  at  the  first  scan  (dotted  
line)  at  ca.  -1.65 V and no anodic peak is detected. The short preconcentration time applied results in 
a great enhancement of the peak intensity as compared with the
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Figure    1.    Successive    (—first    scan)    cyclic    voltammograms    for    a    
urine sample  containing  19.7 mmol L-1   of  venlafaxine  and  1.25 x 10-2 
mol L-1   borate buffer  (pH ¼ 8.7)  after  10 s  deposition  at  -1.00 V.  Scan  
rate:  100 mV s-1.  No accumulation  was  performed  before  the  second  
scan. 
 
response obtained at the second scan performed without deposition (con- tinuous line). The scan rate was 
varied between 60 mV s-1  and 400 mV s-1 and  it  was  observed  that  the  cathodic  peak  current  was  
linearly  depen- dent   on   the   scan   rate   (i  (nA) ¼ -22.0 - 0.106 x  scan   rate   (mV s-1); r ¼ 0.998;  n ¼ 11).  
This  relation  proved  that  the  reduction  of  V  is  con- trolled  by  adsorption  of  the  reactant  at  the  
MFM.  The  absence  of  the anodic  peak  indicated  that  the  reduction  is  irreversible  which  was  con- 
firmed by the linear relationship obtained between the peak potential and the  logarithm  of  the  scan  rate  (E 
(V) ¼ -1.48  -0.0867 x log  (scan  rate); r ¼ 0.997;  n ¼ 11;  scan  rate  varied between  60 mV s-1-400 mV s-1). 
 
Deposition Potential and Reproducibility 
 
The  effect  of  the  preconcentration  potential  on  the  peak  height  was evaluated by ranging the potential 
i/
n
A
 
 
from -0.30 V to -2.00 V. It is evident from the data plotted in Fig. 2 that the highest peak current was 
reached 
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Figure 2.    Effect of the deposition potential on the venlafaxine peak current 
in a urine  sample  containing  19.7 mmol L-1   of  venlafaxine  and  1.25 x 
10-2 mol L-1 borate  buffer  (pH ¼ 8.7)  after  10 s  deposition. 
 
using  -1.00 V  as  deposition  potential  (no  peak  was  detected  using  the deposition  potential  at  -1.90 V  
and  -2.00 V). 
To reduce the fouling of the MFM surface due to adsorption of the products  of  reaction  and  to  
enhance  the  reproducibility,  a  conditioning potential   of   -2.00 V   was   selected.   This   cleaning   
step   was   always performed,  during  30 s,  before  each  new  scan. 
In  order  to  investigate  the  reproducibility  of  the  response  of  the MFM  in  urine  samples  using  
the  conditioning  step,  scans  of  the  same solution were run during ca. 1 h. A RSD value of 4.05% (-
34.6 ± 1.4 nA) was  obtained  for  the  peak  height  measurements. 
 
 
pH 
 
The main factor influencing V peak shape and peak height was the solution pH. The marked pH effect 
was evaluated over the pH range 4.1–9.9 (in increments of  ca.  0.5)  using  Britton-Robinson  buffer. 
Figure 3 shows the main results. From the analysis of this plot, the optimum pH appears to be between 
ca. 8.5 (Fig.  3,  curve  b)  and 9.0 (Fig.  3  curve  c).  Acidic  and  neutral  pH  values  rendered  the  
baseline 
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Figure 3.    Effect of varying pH on the adsorptive stripping peak height in a 
urine sample  containing  9.86 mmol L-1   of  venlafaxine  and  Britton-
Robinson  buffer. Deposition:   10 s   at   -1.00 V.;   (a)   pH ¼ 4.1;   (b)   pH ¼ 
8.5;   (c)   pH ¼ 9.0;   (d) pH ¼ 9.9. 
 
slope so high that the peak was not well-defined and current measure- ments were difficult. pH values 
higher than ca. 9.0 provoked a decrease in peak current. 
For selecting the optimal pH, another assay was performed (not shown) but this time a smaller pH range 
was chosen, i.e., between 8.1 and 9.0. The results obtained showed that, between ca. 8.6 and 8.9, the 
peak is better defined and current remained approximately constant. The choice of pH ¼ 8.7 appeared to 
be adequate considering that at this value the current is almost unaffected by small variations of pH. 
Borate buffer was selected as the supporting electrolyte since it is an effective buffer to fix pH at the 
optimal value and does not interfere with the analysis of V in urine. 
No effect on the peak potential was observed on varying the pH from 4.1 to 9.9. 
 
 
Deposition Time 
 
The   effect   of   the   accumulation   time   (between   0   and   300 s)   was investigated  in  a  urine  sample  
containing  9.86 mmol L-1  of  V  and  it  was observed that the peak height increases linearly with the 
deposition time 
i/
n
A
 
  
 
  
between 0 and 15 s  (i (nA) ¼ -5.87–0.518 x deposition time (s); r ¼ 0.998; n ¼ 6)     and     then     tended     
to     reach     a     plateau,     indicating     that gradual saturation of the MFM occurred following a 
typical adsorption isotherm   behavior.   Obviously,   as   the   determination   of   the   limit   of detection  
will  show,  the  linear  relationship  between  peak  intensity  and collection   time   may   be   extended   in   
samples   containing   lower   bulk concentrations of the drug. Accumulation curves obtained for urine 
samples also showed that maximum adsorption was reached with a shorter deposition time than in 
aqueous  solution,  probably  owing  to the presence of natural surfactants in urine, which competed 
for the adsorption sites of the MFM. In all analyses carried out, the maximum deposition time used 
was 30 s, i.e., experimental conditions that fall within the initial zone of the accumulation curves 
where the maximum peak current: deposition time: concentration ratios are attainable, were always 
applied. 
Due  to  the  inherent  properties  of  microelectrodes,[9–10]   no forced  
convection during the deposition step and no equilibration  period before the cathodic scan were used. 
 
Instrumental Parameters 
 
Optimization of the square-wave parameters indicated that an ampli- tude  of  20 mV,  a  staircase  step  of  
5 mV  and  a  frequency  of  100 Hz  were the most suitable for V quantification in urine samples taking in 
consid- eration the peak definition (when smaller amplitudes were used the base- line  became  smoother  
and  the  peak  shape  was  improved;  high  staircase step resulted in peak distortion), the sensitivity (the 
peak height increased sharply and linearly till 150 Hz: i (nA) ¼ -20.4 -0.0767 x frequency (Hz); r ¼ 0.999; 
n ¼ 15) and the speed of analysis. The high scan rate used, 500 mV/s, promoted a good sensitivity 
probably due to the stronger nature of the drug adsorption  when  compared  to  the  adsorptive  
properties of other surface-active compounds present in urine. 
 
 
Linearity Range, Detection Limit, Accuracy, and Precision 
 
A sample containing 1.27 mmol L-1  of V and the standard additions method were used to establish 
the linearity range (Figs. 4 and 5). With a 30 s deposition time, the peak height increased linearly (i (nA) 
¼ -0.937– 0.797 x [V  (mmol L-1)];  r ¼ 0.9997;  n ¼ 8)  up  to  the  seventh  standard addition   of   V   
(each   of   3.29 mmol L-1)   that   corresponded   to   a   final 
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Figure 4.    Voltammograms  obtained after  7 successive  standard  additions 
in  an urine  sample  containing  1.27 mmol L-1   of  venlafaxine  and  1.25 x 
10-2 mol L-1 borate  buffer  (pH ¼ 8.7)  for  determining  the  linearity  
range.  30 s  deposition  at 
-1.00 V. 
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Figure 5.    Standard additions method in a urine sample containing 1.27 
mmol L-1 and  1.25 x 10-2 mol L-1   borate  buffer  (pH ¼ 8.7)  for  
determining  the  linearity range.   Peak   current   vs.   added   venlafaxine   
concentration.   30 s   deposition   at 
-1.00 V. 
  
 
 
Table 1. Results of the determination of venlafaxine in 
three spiked urine samples. RSD: relative standard 
deviation; n: number of quantifications performed. 
 
Amount  
added (mmol 
L-1) 
 
n 
Found 
(mmol L-
1) 
RSD 
(%) 
Bias 
(%) 
4.93 3 5.12±0.013 0.25 þ3.9 
7.95 3 7.69±0.27 3.5 -3.3 
14.4 3 14.4±0.37 2.6 -1.8 
 
concentration  of  24.3 mmol L-1   in  the  sample.  When  further  standard additions  were  made,  
deviations  from  linearity  became  significant  due to   the   saturation   of   the   MFM   (Fig.   5).  The   
mean   equation  of   the linear   part   of   the   plot   was   used   to   calculate   the   limit   of   detection 
(LOD),  as  recommended  by  IUPAC,[17]   and  a  value  of  0.693 mmol L-1 was  obtained. 
The accuracy of V determination was tested by three recovery experiments doing three 
quantifications (n) of the same urine sample (each   quantification   was   performed   by   five   
standard   additions  of 1.64mmol L-1   with  three  replicates  at  each  concentration).  The  results   
obtained are presented in Table 1. Bias less than 5% proved that the developed method is 
accurate at the concentration level studied  and that the assays precision, expressed in terms of the 
relative standard deviation, is satisfactory (0.25–3.5%). 
 
 
CONCLUSIONS 
 
While no previous data, at the knowledge of this research team, are available regarding the 
voltammetric quantification of V in biological fluids, the present work demonstrates that this can be 
successfully accom- plished, in urine, using a MFM and adsorptive stripping voltammetry. Interferences 
from organic compounds and, particularly, surface-active substances present in the biological matrix 
were minimized by various approaches to avoid performing an extraction step. A ten-fold dilution of 
urine samples was performed. The use of a MFM eliminated the need for convection by hydrodynamics 
during the deposition step and reduced the pre-concentration time: these factors are particularly 
advantageous for analysis of biological fluids since longer accumulation times and stirring of the 
solution enhance the diffusion of interfering large compounds which normally diffuse very slowly to the 
electrode surface in  quiescent 
  
 
 
solutions.  The standard additions  method  was applied.  However,  if V is to  be  analyzed  in  media  with  
much  higher  content  of  organic  matter (blood, serum, etc.) simple cleanup procedures (e.g., extraction or 
protein precipitation),  common  in  the  clinical  laboratory,  that  may  be  coupled with  the  medium  
exchange  procedure[18]   and  higher  dilutions  may  be required. The method proposed for the 
determination of V in urine sam- ples  is  comparable to most published chromatographic methods in what 
concerns  the  linearity  range  (D.  R.  Hicks  et  al.  referred  an  analytical range   of   0.319–31.9 mmol L-
1[3];   M.   Matoga   et   al.   reported   a   linear response   between   0.637 mmol L-1    and   12.7 mmol L-
1[19];   these   groups did  not  presented  LOD  values  and  consequently  no  direct  comparison is   possible   
since   the   referred   chromatographic   methods   employed laborious  and  complex  
extraction/preconcentration  procedures  lacking specificity. A separation step will be needed for improving 
the selectivity of  the  developed  adsorptive  stripping  voltammetric  procedure,  e.g.,  for differentiating  
between  the  parent  compound  and  its  major  metabolite (o-desmethylvenlafaxine). However, it is 
worthwhile to note that disposal of   toxic   or   inflammable   solvents   is   avoided   (which   is   particularly 
important  when  daily  routine  analyses  are  made)  and  that  the  LOD obtained  is  adequate  to  detect  
as  little  as  1%  of  the  50 mg  pharmacolo- gical   dose   of   V   excreted   over   a   24 h   period[3]    being,   
consequently, appropriate  to  monitor  therapeutic  or  toxic  concentrations  in  urine. 
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